BioNTech shares slip on gloomy Covid vaccine sales outlook
March 27, 2023 at 12:00 PM EDT
The shares initially fell by 6.4% to an intraday low of $119.98 a share before recovering most of those losses in late morning trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.